LIST OF WITNESSES TO APPEAR BEFORE
COMMITTEE ON WAYS AND MEANS
ON LEGISLATION TO COVER PRESCRIPTION DRUGS UNDER MEDICARE


TUESDAY, JUNE 13, 2000 - BEGINNING AT 10:00 A.M.
ROOM 1100 LONGWORTH HOUSE OFFICE BUILDING


Opening Statements:

PANEL:

The Honorable William M. Thomas, M.C., California

The Honorable Benjamin L. Cardin, M.C., Maryland

The Honorable Edward M. Kennedy, U.S.S., Massachusetts

The Honorable John Breaux, U.S.S., Louisiana

The Honorable Collin C. Peterson, M.C., Minnesota

The Honorable Anna G. Eshoo, M.C., California

The Honorable Thomas H. Allen, M.C., Maine


The Honorable Nancy-Ann DeParle, Administrator, Health Care Financing Administrator;
     accompanied by
Gary Claxton, Deputy Assistant Secretary for Health Policy, U.S. Department of Health and Human Services


PANEL:

Karen Ignagni, President and Chief Executive Officer, American Association of Health Plans

Craig L. Fuller, President and Chief Executive Officer, National Association of Chain Drug Stores, Alexandria, Virginia

Judith H. Bello, Executive Vice President, Policy and Strategic Affairs, Pharmaceutical Research and Manufacturers of America

Deborah Briceland-Betts, J.D., Executive Director, Older Women's League

Patrick B. Donoho, Vice President, Government Affairs & Public Policy, Pharmaceutical Care Management Association, Arlington, Virginia

Stephen W. Schondelmeyer, Pharm.D., Ph.D., Head, Department of Pharmaceutical Care and Health Systems, and Professor, Pharmaceutical Management and Economics, University of Minnesota

Charles N. Kahn III, President, Health Insurance Association of America